| Domain | Rank | Visitors | Earning per month | Valuation |
| cgirb.com | None | 0 | 0$ | 1000$ |
| wirb.com | None | 0 | 0$ | 1000$ |
| connexus.com | 9210 | 44,752 | 40,953$ | 1228590$ |
| connexuscu.org | 197031 | 2,240 | 854$ | 25620$ |
| wcgirb.com | None | 81$ | 2430$ | |
| mlirb.com | None | 0 | 0$ | 1000$ |
| neirb.com | None | 0 | 0$ | 1000$ |
| aspire-irb.com | None | 0 | 0$ | 1000$ |
| Moz Backlinks Count | 220 |
| Moz Page Rank | 3 |
| Domain Authority (DA) | 33.0 |
| Page Authority (PA) | 34.0 |
| Country | Rank | Pct |
|---|
| Country Name | United States |
| Country Rank | 111287
364363
|
| Daily unique visits | 2,568 |
| Daily Page Views | 7,960 |
| Income Per Day | 740 USD |
| Wcgclinical.com valuation | 22200 |
| Type | Status |
| HTML 5 | 
|
| Responsive Website | 
|
| No | Text |
| 1 | The trusted partner for 93% of all FDA-approved therapeutic agents last year. |
| No | Text |
| 1 | What’s slowing down your clinical trials? |
| 2 | WCG by the numbers |
| 3 | A trusted partner for more than 55 years |
| 4 | Mid-sized BioPharma Closes Enrollment 3 Months Ahead of Schedule |
| 5 | A few of the places our scientific and clinical operations thought leaders are featured: |
| No | Text |
| 1 | Long study start-up and trial duration? |
| 2 | Increased competition for sites and participants? |
| 3 | Increased protocol complexity? |
| 4 | Understanding the FDA’s new proposed regulations on human subject research and their impact on your clinical trial plans |
| 5 | Diversity Action Plans Will Soon Be Mandatory for Clinical Trials |
| 6 | WCG Releases 2023 Report on Top Issues Impacting Clinical Research Sites |
| 7 | In Focus Topics |
| 8 | Clinical Endpoints |
| 9 | Clinical Trial Safety |
| 10 | Billing Compliance Webinar Part 3: Ask the Experts: Your Coverage Analysis & Billing Compliance Questions Answered |
| 11 | The Inflation Reduction Act: How Will It Impact Drug Development? |
| 12 | MAGI 2024: The Clinical Research Conference |
| No | Text |
| 1 | Explore our solutions for: |
| 2 | Explore our approach to |
| 3 | years experience in independent review solutions |
| 4 | biopharma and CRO clients (including 50 of 50 top pharma and 8 of 8 top CROs) |
| 5 | participants in WCG-supported studies |
| Social | Count |
| Facebook Likes | 4 |
| Reddit score | 0 |
| Pinterest Share Count | 0 |
| Vk Share Count | 0 |
| OK Share Count | 0 |